Castleman patient benefits from Every Cure's AI Model! 

Al walked into the ER in August of 2020 with symptoms of fever and abdominal pain, his doctors first thought it was COVID, but it was worse, it was idiopathic multicentric Castleman disease (iMCD).
iMCD is a rare and life-threatening disorder that involves hyperactivation of the body’s immune system which causes uncontrolled organ dysfunction. The only FDA-approved treatment works in a portion of those diagnosed with iMCD, leaving the majority of patients like Al with limited options.
Al went on a 2-year journey of taking new drugs, going into remission, and relapsing before his doctor contacted David Fajgenbaum, MD, MBA, MSc and the Every Cure team...